Latest news and press releases about GP-Act III Acquisition Corp. (GPAT): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
GP-Act III Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. The company was incorporated in 2020 and is based in New York, New York.
Price
| Price | $11.15 |
| Market Cap | $401M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 46.07 |
| Price / Book | 3.11 |
| EV / EBITDA | -177.16 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 3.50% |
| Return on Invested Capital | -2.32% |
| Return on Assets | 8.58% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ALF · BEAG · CCIX · CEPT · GIG · HYAC · MBAV
Explore sector: Financial Services · Shell Companies
More sections of GPAT: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks